Dekabank Deutsche Girozentrale Reduces $2M in ANI Pharmaceuticals, Inc. ($ANIP)
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Dekabank Deutsche Girozentrale reduced its position in ANI Pharmaceuticals, Inc. ($ANIP), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 0 shares of ANI Pharmaceuticals, Inc. after selling 23,022 shares during the quarter.
ANI Pharmaceuticals, Inc. Stock Up 15.2%
Shares of ANI Pharmaceuticals, Inc. ($ANIP) traded around $83.90 on Saturday, up 15.2% for the day.
ANI Pharmaceuticals, Inc. Earnings
Analysts Set New Price Targets
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Get ANI Pharmaceuticals, Inc. alerts
New 13F filings, insider trades, and analyst moves on $ANIP, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.